Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Minimally invasive stent graft for aortic aneurysm under Real-World scrutiny

NCT ID NCT07674173

Disease control Sponsor: Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study follows about 200 people with abdominal aortic aneurysms who receive the Minos stent graft, a device placed through small groin incisions to reinforce the weakened aorta. Researchers track how well the device works and its safety over up to 5 years in everyday hospital settings. The goal is to see if the stent graft performs reliably outside of controlled clinical trials.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Minos Abdominal Aortic Stent-Graft and Delivery System
What this could lead to
If successful, this registry could confirm that the Minos stent graft is a safe and effective option for minimally invasive aneurysm repair in everyday practice.
What could go wrong
This is an observational study, not a controlled trial, so results may be less definitive. Long-term risks like device migration or endoleaks remain possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2023

Expected to finish

Jan 2033

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Chinese and European subjects suffering abdominal aortic aneurysm with a proximal neck length ≥15mm.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of infrarenal abdominal aortic aneurysm * Plan to treat with Minos Abdominal Aortic Stent-Graft and Delivery System * Voluntary participation and completion of Informed Consent Form, with willingness to participate in follow-up to 5 years post-procedure Exclusion Criteria: * Subjects in whom use of the Minos™ Abdominal Aortic Stent-Graft and Delivery System is contraindicated, as follows: * Severe stenosis or calcification near the aneurysm, leading to difficulty in achieving apposition of vessel wall and stent graft. * Difficult access due to severe stenosis or tortuosity in the iliac artery or femoral artery. * Subjects with ruptured aneurysm or acute aneurysm. * Subjects with an infectious aneurysm. * Those who are allergic to contrast agents or unable to tolerate contrast agents due to renal insufficiency. * Patients with severe coagulation disorder and/or high risk of postoperative hemorrhage. * Aneurysmal neck angulation greater than 60°. * Patients with blood supply to vital organs originating from the aneurysmal sac. * Patients with other comorbidities and whose life expectancy does not exceed one year. * Subjects with connective tissue diseases, such as Marfan syndrome. * Minors and pregnant women. * Subjects who are allergic to nitinol. * Subjects who are considered not suitable for treatment with stent graft.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Endovascular repair of infrarenal abdominal aortic aneurysm using endovascular stent graft are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

abdominal aortic aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Endovascular repair of infrarenal abdominal aortic aneurysm using endovascular stent graft

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    16 sites in 6 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • "G. Gennimatas" Thessaloniki General Hospital

    RECRUITING

    Thessaloniki, GR54635, Greece

  • Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (ASST Spedali Civili di Brescia)

    NOT_YET_RECRUITING

    Brescia, 25123, Italy

  • Erasmus MC

    RECRUITING

    Rotterdam, 3015 GD, Netherlands

  • Fuwai Hospital

    RECRUITING

    Beijing, 100037, China

  • Hospital Universitari de Girona Doctor Josep Trueta

    NOT_YET_RECRUITING

    Girona, Catalonia, 17007, Spain

  • Hunan Provincial People's Hospital

    RECRUITING

    Changsha, Hunan, 410002, China

  • Klinikverbund Allgäu

    RECRUITING

    Immenstadt im Allgäu, Allgäu, 87439, Germany

  • Kunming Yan'an Hospital

    RECRUITING

    Kunming, Yunnan, 650051, China

  • Meizhou People's Hospital

    RECRUITING

    Meizhou, Guangdong, 514031, China

  • TEDA International Cardiovascular Hospital

    RECRUITING

    Binhai, Tianjin Municipality, 300457, China

  • The Second Hospital of Lanzhou University

    RECRUITING

    Lanzhou, Gansu, 730030, China

  • The University of Hong Kong - Shenzhen Hospital

    RECRUITING

    Shenzhen, Guangdong, 518053, China

  • Universitätsklinikum Münster (UKM)

    RECRUITING

    Münster, 48149, Germany

  • Xiangtan Central Hospital

    RECRUITING

    Xiangtan, Hunan, 411100, China

  • Yueyang Central Hospital

    RECRUITING

    Yueyang, Hunan, 414000, China

  • Zibo Central Hospital

    RECRUITING

    Zibo, Shandong, 255024, China